Search

Search Constraints

You searched for: Author/Creator Ho, Meilien

Search Results

1. Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease. Issue 10 (8th February 2016)

2. Effects of Fostamatinib, an Oral Spleen Tyrosine Kinase Inhibitor, in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study1. Issue 12 (December 2014)

3. How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries. Issue 10 (30th November 2015)

4. Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme. Issue 2 (10th October 2017)

6. Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries. Issue 12 (December 2015)

7. OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy. Issue 12 (29th July 2014)

8. Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach‡. (25th August 2015)